Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4.

MLA

Li, Chuansheng, et al. “Discovery of Novel Anti-Angiogenesis Agents. Part 7: Multitarget Inhibitors of VEGFR-2, TIE-2 and EphB4.” European Journal of Medicinal Chemistry, vol. 141, Dec. 2017, pp. 506–18. EBSCOhost, https://doi.org/10.1016/j.ejmech.2017.10.030.

APA

Li, C., Shan, Y., Sun, Y., Si, R., Liang, L., Pan, X., Wang, B., & Zhang, J. (2017). Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4. European Journal of Medicinal Chemistry, 141, 506–518. https://doi.org/10.1016/j.ejmech.2017.10.030

Chicago

Li, Chuansheng, Yuanyuan Shan, Ying Sun, Ru Si, Liyuan Liang, Xiaoyan Pan, Binghe Wang, and Jie Zhang. 2017. “Discovery of Novel Anti-Angiogenesis Agents. Part 7: Multitarget Inhibitors of VEGFR-2, TIE-2 and EphB4.” European Journal of Medicinal Chemistry 141 (December): 506–18. doi:10.1016/j.ejmech.2017.10.030.